Free Trial

DSS (DSS) SEC Filings & 10K Form

DSS logo
$0.86 0.00 (-0.19%)
As of 04:10 PM Eastern

Recent DSS SEC Filings

DateFilerForm TypeView
12/30/2024
3:30 PM
DSS (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:24 PM
DSS (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
8:56 PM
Chan Heng Fai Ambrose (Filed by)
DSS (Subject)
Form SC 13D/A
12/12/2024
8:49 PM
Alset Inc. (Reporting)
Chan Heng Fai Ambrose (Reporting)
DSS (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:54 PM
DSS (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:16 PM
DSS (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
11:15 PM
DSS (Filer)
Form EFFECT
10/31/2024
4:08 PM
DSS (Filer)
Form S-3/A
10/22/2024
4:29 PM
DSS (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
4:20 PM
DSS (Filer)
Form 10-K/A
10/22/2024
4:25 PM
DSS (Filer)
Form DEF 14A
09/19/2024
6:07 PM
DSS (Reporting)
IMPACT BIOMEDICAL INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
7:52 PM
DSS (Reporting)
IMPACT BIOMEDICAL INC. (Issuer)
Form 3/A
09/18/2024
7:53 PM
DSS (Reporting)
IMPACT BIOMEDICAL INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:16 AM
DSS (Reporting)
IMPACT BIOMEDICAL INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
4:18 PM
DSS (Filer)
Form 8-K/A
08/13/2024
3:31 PM
DSS (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/27/2024
3:31 PM
DSS (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/22/2024
3:54 PM
DSS (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEAMERICAN:DSS) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners